An interventional study of WeChat Quit Coach and Leaflet in Smoking Cessation, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Other
The study team will develop and assess the feasibility and acceptability of a WeChat-based peer-group mobile messaging smoking cessation intervention targeting Chinese immigrant smokers in New York City (NYC). For Aim 1, the study team will develop a message library for the WeChat Quit Coach smoking cessation program and conduct in-depth interviews with 20 Chinese immigrant smokers in person to assess content relevance. For Aim 2, a two-arm, open-labeled, pilot randomized controlled trial (RCT) will be conducted to test the feasibility and acceptability of the WeChat Quit Coach intervention among 60 Chinese immigrant smokers. Participants will be randomized to intervention (n=40) or control group (n=20). Participants in the intervention group will receive a 6-week WeChat Quit Coach intervention through WeChat private group. Participants in the control group will receive a leaflet with information about existing smoking cessation programs that focus on Chinese American smokers. All the 60 participants will be offered a 4-week supple of nicotine replacement therapy (NRT) patches and/or lozenges. Participants will complete a baseline in-person survey at enrollment, a 6-week follow-up phone survey immediately after the intervention, and a 6-month follow-up phone survey. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7-day at 6-week and 6-month follow-up surveys. Post-test in-depth interviews will be conducted with at least 20 participants in person from the intervention group at 6-week follow-up to obtain more information about the usability and perceptions about the WeChat Quit Coach program. For Aim 3, the investigators will conduct an open-labeled, 3-arm pilot RCT to test the preliminary effectiveness of the WeChat Quit Coach intervention with 90 Chinese immigrant smokers. Participants will be randomized to one of the three groups, including a 6-week intervention group A (IA; n = 30), a 12-week intervention group B (IB; n = 30), and a control group (n = 30). Participants in the intervention groups will either receive a 6-week (IA) or 12-week (IB) WeChat Quit Coach intervention through WeChat private groups. Participants in the control group will receive a leaflet with information of existing smoking cessation programs targeting Chinese American smokers. All 90 participants will be offered a 4-week free supply of NRT patches and/or lozenges. Participants will complete a baseline phone survey at enrollment, 12-week and 6-month follow-up phone surveys. A remote biochemical validation (saliva cotinine test) will be conducted at 12-week and 6-month follow-up to confirm smoking abstinence among those who self-report no smoking in the past 7 days. Post-test in-depth phone interviews will be conducted with up to 30 intervention participants to obtain more information about their perceptions and experience with the WeChat Quit Coach program.
304 studies on the registry are indexed under Smoking Cessation; 139 are open to participants now.
This study's enrollment of 150 is close to the median of 154 across 285 interventional studies indexed under Smoking Cessation.
Browse Smoking Cessation studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Aim 2:
Aim 3:
Exclusion Criteria:
Aim 2:
Aim 3:
Participants will be assigned to a 6-week intervention period.
Behavioral: WeChat Quit Coach · Drug: Optional Nicotine Replacement Therapy (NRT) Patches or Lozenges
Participants will be assigned to a 12-week intervention period.
Behavioral: WeChat Quit Coach · Drug: Optional Nicotine Replacement Therapy (NRT) Patches or Lozenges
Behavioral: Leaflet · Drug: Optional Nicotine Replacement Therapy (NRT) Patches or Lozenges
WeChat Quit Coach intervention will be delivered via WeChat private groups for 6-12 weeks (\<30 seconds per day). During the intervention period, participants will receive a text message at a fixed point of time every day (e.g., 8:00 am). The messages are designed to build motivations and skillset to quit smoking. Participants will also receive a daily group discussion question (e.g., "If you are to give one piece of advice to someone who has not made the decision to quit smoking, what would you say to his/her?"), and be encouraged to respond to the question. Participants can comment on group members' responses and ask questions related to smoking and quitting either in group (so everyone in the group can see the message) or directly to the coach (so only the coach can see the message). The coach will respond to the questions within 24 hours. The PI and the RA will moderate group discussions.
Participants in the control group will receive a leaflet with information about existing smoking cessation programs targeting Chinese American smokers.
Participants in both groups will be offered a 4-week supply of NRT patches and lozenges but not forced to use the medications. The medications are free to participants. If participants want to try or use the medications, the study team will mail the patches and lozenges (with a Chinese version of the instruction) or deliver in person.
Also known as: Habitrol, Nicorette
Number of Participants Who Respond to Daily Text Questions
Measure of engagement. Measured among Aim 2 participants only.
Time frame: Up to Week 6 Follow-Up
Number of Participants Who Asked Self-Composed Questions
Measure of engagement. Measured among Aim 2 participants only.
Time frame: Up to Week 6 Follow-Up
Number of Satisfied Participants Per WeChat Program Participant Satisfaction Score
A 5-point Likert scale will be used to report satisfaction. The total range in score is 1-5; the higher the score, the higher the satisfaction. Measured among Aim 2 participants only.
Time frame: Up to Week 6 Follow-Up
Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only.
Time frame: Month 6 Follow-Up
Percentage of Participants With Quit Attempts at Week 6
Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Percentage of Participants With Quit Attempts at Week 12
Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Percentage of Participants With Quit Attempts at Month 6
Measured among Aim 2 participants only.
Time frame: Month 6 Follow-Up
Average Daily Cigarette Consumption at Week 6
Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Change in Average Daily Cigarette Consumption at Week 12
Measured among Aim 3 participants only.
Time frame: Baseline, Week 12 Follow-Up
Change in Average Daily Cigarette Consumption at Month 6
Measured among Aim 3 participants only.
Time frame: Baseline, Month 6 Follow-Up
Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 6
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 12
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 2 participants only.
Time frame: Month 6 Follow-Up
Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 6
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 12
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Month 6
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among aim 3 participants only.
Time frame: Month 6 Follow-Up
Average Score or Knowledge About Harms of Smoking at Week 6
Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Average Score or Knowledge About Harms of Smoking at Week 12
Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Self-Efficacy for Quitting Smoking Score at Week 6
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Self-Efficacy for Quitting Smoking Score at Week 12
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Self-Efficacy for Quitting Smoking Score at Month 6
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 2 participants only.
Time frame: Month 6 Follow-Up
Percentage of Participants With Progression on Stage of Change for Smoking Cessation at Week 6
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Percentage of Participants With Progression on Stage of Change for Smoking Cessation at Week 12
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Number of Participants With Progression on Stage of Change for Smoking Cessation at Month 6
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only.
Time frame: Month 6 Follow-Up
Percentage of Participants Who Report NRT Use During Intervention Period at Week 6
Measured among Aim 2 participants only.
Time frame: Week 6 Follow-Up
Number of Participants Who Report NRT Use During Intervention Period at Week 12
Measured among Aim 3 participants only.
Time frame: Week 12 Follow-Up
Number of Participants Who Report NRT Use During Intervention Period at Month 6
Measured among aim 3 participants only.
Time frame: Month 6 Follow-Up
| Milestone | Interview Participants (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|---|---|---|
| Started | 20 | 20 | 20 | 30 | 30 | 30 |
| Completed | 20 | 20 | 20 | 30 | 30 | 30 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
Measure of engagement. Measured among Aim 2 participants only.
| Participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Number of Participants Who Respond to Daily Text Questions | 20 | — |
Measure of engagement. Measured among Aim 2 participants only.
| Participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Number of Participants Who Asked Self-Composed Questions | 9 | — |
A 5-point Likert scale will be used to report satisfaction. The total range in score is 1-5; the higher the score, the higher the satisfaction. Measured among Aim 2 participants only.
| Participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Number of Satisfied Participants Per WeChat Program Participant Satisfaction Score | 19 | — |
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6 | 40 (20 to 60) | 37 (18.5 to 55.5) | 10 (5 to 15) |
Measured among Aim 2 participants only.
| Percentage of participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Percentage of Participants With Quit Attempts at Week 6 | 55 | 35 |
Measured among Aim 3 participants only.
| Percentage of participants | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Percentage of Participants With Quit Attempts at Week 12 | 81 | 89 | 63 |
Measured among Aim 2 participants only.
| Percentage of participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Percentage of Participants With Quit Attempts at Month 6 | 75 | 65 |
Measured among Aim 2 participants only.
| Cigarettes per day | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Average Daily Cigarette Consumption at Week 6 | 7.2 ± 4.1 | 9 ± 4.7 |
Measured among Aim 3 participants only.
| Cigarettes per day | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Change in Average Daily Cigarette Consumption at Week 12 | -3.81 ± 7.38 | -6.5 ± 6.65 | -6.5 ± 11.49 |
Measured among Aim 3 participants only.
| Cigarettes per day | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Change in Average Daily Cigarette Consumption at Month 6 | -6.88 ± 6.74 | -7.86 ± 9.43 | -6.02 ± 12.25 |
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 2 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 6 | 20 (10 to 30) | 0 (0 to 0) |
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 12 | 37 (18.5 to 55.5) | 37 (18.5 to 55.5) | 13 (6.5 to 19.5) |
Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 2 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6 | 25 (12.5 to 37.5) | 15 (7.5 to 22.5) |
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 2 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 6 | 20 (10 to 30) | 0 (0 to 0) |
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 3 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 12 | 23 (11.5 to 34.5) | 10 (5 to 15) | 0 (0 to 0) |
Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among aim 3 participants only.
| Percentage of Days Abstinent | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Month 6 | 27 (13.5 to 40.5) | 17 (8.5 to 25.5) | 10 (5 to 10) |
Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 2 participants only.
| score on a scale | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Average Score or Knowledge About Harms of Smoking at Week 6 | 1.6 ± 1.6 | 0.3 ± 1 |
Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 3 participants only.
| score on a scale | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Average Score or Knowledge About Harms of Smoking at Week 12 | 1.33 ± 1.75 | 1.56 ± 1.31 | 0.74 ± 1.65 |
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 2 participants only.
| score on a scale | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Self-Efficacy for Quitting Smoking Score at Week 6 | 48.4 ± 12.2 | 45.1 ± 10.6 |
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 3 participants only.
| score on a scale | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Self-Efficacy for Quitting Smoking Score at Week 12 | 46.6 ± 11.4 | 43.4 ± 15.3 | 43.7 ± 12.8 |
12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 2 participants only.
| score on a scale | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Self-Efficacy for Quitting Smoking Score at Month 6 | 51.1 ± 13.2 | 50.2 ± 11.8 |
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 2 participants only.
| Percentage of participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Percentage of Participants With Progression on Stage of Change for Smoking Cessation at Week 6 | 40 | 0 |
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only.
| Percentage of participants | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Percentage of Participants With Progression on Stage of Change for Smoking Cessation at Week 12 | 50 | 40 | 5 |
The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only.
| Percentage of participants | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Number of Participants With Progression on Stage of Change for Smoking Cessation at Month 6 | 60 | 48 | 18 |
Measured among Aim 2 participants only.
| Percentage of participants | Intervention Group A (Aim 2) | Control Group (Aim 2) |
|---|---|---|
| Percentage of Participants Who Report NRT Use During Intervention Period at Week 6 | 55 | 70 |
Measured among Aim 3 participants only.
| Percentage of participants | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Number of Participants Who Report NRT Use During Intervention Period at Week 12 | 56 | 63 | 59 |
Measured among aim 3 participants only.
| Percentage of participants | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) |
|---|---|---|---|
| Number of Participants Who Report NRT Use During Intervention Period at Month 6 | 61 | 64 | 71 |
Collected over 6 Months.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Intervention Group A (Aim 2) | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Control Group (Aim 2) | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Intervention Group A (Aim 3) | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Intervention Group B (Aim 3) | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Control Group (Aim 3) | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Age, Continuous(years) | Interview Group (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) | Total |
|---|---|---|---|---|---|---|---|
| Mean | 37.5 ± 10.4 | 45.5 ± 13.5 | 42.5 ± 14.8 | 47.53 ± 11.95 | 36.87 ± 11.88 | 38.03 ± 14.17 | 40.81 ± 13.46 |
| Sex: Female, Male(Participants) | Interview Group (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) | Total |
|---|---|---|---|---|---|---|---|
| Female | 7 | 6 | 5 | 8 | 5 | 8 | 39 |
| Male | 13 | 14 | 15 | 22 | 25 | 22 | 111 |
| Ethnicity (NIH/OMB)(Participants) | Interview Group (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) | Total |
|---|---|---|---|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not Hispanic or Latino | 20 | 20 | 20 | 30 | 30 | 30 | 150 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Interview Group (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) | Total |
|---|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 20 | 20 | 20 | 30 | 30 | 30 | 150 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| White | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| More than one race | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Region of Enrollment(participants) | Interview Group (Aim 1) | Intervention Group A (Aim 2) | Control Group (Aim 2) | Intervention Group A (Aim 3) | Intervention Group B (Aim 3) | Control Group (Aim 3) | Total |
|---|---|---|---|---|---|---|---|
| United States | 20 | 20 | 20 | 30 | 30 | 30 | 150 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.
Supporting information: Study protocol, Sap
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health